Baird Financial Group’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$679K Hold
237,522
– – ﹤0.01% 1464
2026
Q2
$722K Hold
237,522
– – ﹤0.01% 1428
2026
Q1
$732K Buy
237,522
+118,082
+99% +$501K ﹤0.01% 1360
2025
Q4
$431K Hold
119,440
– – ﹤0.01% 1526
2025
Q3
$450K Buy
119,440
+60,000
+101% +$232K ﹤0.01% 1505
2025
Q2
$230K Hold
59,440
– – ﹤0.01% 1668
2025
Q1
$297K Hold
59,440
– – ﹤0.01% 1563
2024
Q4
$429K Buy
+59,440
New +$454K ﹤0.01% 1433

Other funds holding ALT

Baird Financial Group's ALT Position: Q3 2026 in Review

Baird Financial Group held its Altimmune (ALT) position steady in Q3 2026 at 237,522 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

Baird Financial Group first reported a position in ALT in Q4 2024 and has held it in 8 quarters since. The position peaked at $732K in Q1 2026. 189 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Baird Financial Group held 237,522 shares of Altimmune worth $679K as of Q3 2026.
  • Baird Financial Group left its Altimmune share count unchanged in Q3 2026.
  • Altimmune made up ﹤0.01% of Baird Financial Group's portfolio in Q3 2026, its #1464 holding.
  • Baird Financial Group first reported a position in Altimmune in Q4 2024 and has held it in 8 quarters since.
  • Baird Financial Group's Altimmune position peaked at $732K in Q1 2026.
  • 189 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Baird Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.